GC2202 Study Site 115 is a clinical research site located in Huntington Park, California, United States 90255.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
GC2202 Study Site 115 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia.
Sponsors: Grifols Therapeutics LLC.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Huntington Park
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
GC2202 Study Site 115 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GC2202 Study Site 115 has 1 clinical trials on record, with 1 currently active. Their work covers Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia.
GC2202 Study Site 115 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.